Related Experiment Video
Updated: Oct 7, 2025

Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice
Published on: December 4, 2020
Device-associated aortic valve endocarditis due to a complicated Enterobacter cloacae urinary tract infection
Dilanthy Annappah1, Mark Saling2, John Prodafikas2
1Department of Internal Medicine, Canton Medical Education Foundation/NEOMED, 2600 6th St SW, Canton OH, 44710, USA.
Abstract:
Infective endocarditis (IE) is a life-threatening infection, which has had a notable increase in incidence in recent years. Although Staphylococci or Streptococci are the most common culprit organisms, rarer organisms have also been implicated and associated with a more aggressive disease course. We present a case of Enterobacter cloacae IE affecting the aortic valve in an 82-year-old male with an implantable permanent pacemaker. Our case demonstrates that a prolonged-course of beta-lactam therapy may be an effective, non-invasive management option for IE caused by multidrug-resistant gram-negative organisms.
Insights
Infective endocarditis (IE) is a serious heart infection. A case of Enterobacter cloacae IE successfully treated with prolonged beta-lactam therapy highlights a potential non-invasive option for resistant gram-negative infections.
Area of Science:
- Cardiology
- Infectious Diseases
- Internal Medicine
Background:
- Infective endocarditis (IE) incidence is rising, with Staphylococci and Streptococci as common causes.
- Rarer organisms are increasingly implicated in IE, often presenting with aggressive disease courses.
- Multidrug-resistant (MDR) gram-negative bacteria pose a significant challenge in IE management.
Observation:
- A case of aortic valve IE caused by Enterobacter cloacae in an 82-year-old male with a permanent pacemaker is presented.
- The patient had a history of multidrug-resistant gram-negative organism infection.
- The infection involved the aortic valve, a critical site for endocarditis.
Findings:
- Enterobacter cloacae, a multidrug-resistant gram-negative organism, was identified as the causative agent of IE.
- A prolonged course of beta-lactam therapy was administered.
- Clinical improvement and successful non-invasive management were observed.
Implications:
- Prolonged beta-lactam therapy may represent an effective non-invasive treatment strategy for IE caused by MDR gram-negative organisms.
- This case broadens the therapeutic options for complex IE cases.
- Further research into beta-lactam efficacy for MDR gram-negative IE is warranted.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Urinary Tract Infection II: Pathophysiology
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.

